Last reviewed · How we verify
NCT06957925
ABC School Intervention Among Ugandan Adolescents
NA trial testing educational in Anxiety in 2,598 participants. Completed in 11 May 2024.
12 May 2023
Quick facts
| Lead sponsor | KU Leuven |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 2,598 |
| Start date | 12 May 2023 |
| Primary completion | 12 May 2023 |
| Estimated completion | 11 May 2024 |
| Sites | 2 locations across Uganda |
Drugs / interventions tested
- educational
Conditions studied
- Anxiety — all drugs for Anxiety →
- Depression Disorders — all drugs for Depression Disorders →
Sponsor
KU Leuven — full company profile →
Who can join
Adults 14 to 17, any sex, with Anxiety or Depression Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Schools can be pivotal in addressing mental health challenges, especially in low-income settings like Uganda. This pilot cluster-randomized trial examines the impact of a culturally sensitive Act-Belong-Commit (ACT) intervention, combined with physical activity, sleep hygiene and stress management measures on anxiety and depression among Ugandan adolescents attending secondary school. Adolescents from four secondary schools were randomized by school to either a 12-week, weekly two-hour teacher- and peer-led ACT intervention or a care-as-usual control. Anxiety (GAD-7) and depression (PHQ-9-A) were measured at baseline and immediately post-intervention. Childhood trauma (CTQ-SF), self-reported health, wealth, and food security were assessed at baseline. Linear mixed modeling was used to evaluate intervention effects.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06957925
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of educational
Trials testing the same drug.
- NCT07136662 — Anderson Fabry Disease - the Power of Information. · NA · completed
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other KU Leuven trials
Trials by the same sponsor.
- NCT07508696 — Cerebellar Research in Ultrasound Stimulation · NA · not yet recruiting
- NCT07476716 — Peer-modeled Intervention · NA · not yet recruiting
- NCT07534384 — Automated CPET Interpretation: International Validation Study · not yet recruiting
- NCT07419555 — Belgian Lung Function Study · recruiting
- NCT07295600 — Postprandial Effect of Isocaloric Challenge Meals Enriched With Indigenous Fruits and Vegetables on Glucose Metabolism i · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06957925 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by KU Leuven
- Last refreshed: 6 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06957925.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing